Journal of International Oncology››2015,Vol. 42››Issue (2): 147-149.doi:10.3760/cma.j.issn.1673-422X.2015.02.018
Previous ArticlesNext Articles
Men Yu, Hui Zhouguang
Online:
2015-02-08Published:
2015-02-02Contact:
Hui Zhouguang E-mail:drhuizg@163.comMen Yu, Hui Zhouguang. Clinicopathological characteristics, diagnosis and treatment of combined small cell lung cancer[J]. Journal of International Oncology, 2015, 42(2): 147-149.
[1] Hage R, Elbers JR, Brutel de la Rivière A, et al. Surgery for combined type small cell lung carcinoma[J]. Thorax, 1998, 53(6): 450-453. [2] Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens[J]. Am J Surg Pathol, 2002, 26(9): 1184-1197. [3] 门玉, 惠周光, 翟医蕊, 等. 混合型小细胞肺癌临床特点及放疗价值[J]. 中华放射肿瘤学杂志, 2013, 22(5): 369-373. [4] 罗洁, 倪健, 郑卉, 等. 肺复合性小细胞癌88例临床分析[J]. 肿瘤, 2009, 29(2): 156-159. [5] 吕旭, 孙蕾娜, 战忠利, 等. 复合性小细胞肺癌临床病理学特征及预后分析[J]. 中国肿瘤临床, 2011, 38(23): 769-777. [6] 罗洁, 李爱武, 吴凤英, 等. NIP与EP方案一线治疗167例晚期复合性小细胞肺癌的回顾性分析[J]. 肿瘤, 2012, 32(3): 194-198. [7] Mangum MD, Greco FA, Hainsworth JD, et al. Combined smallcell and nonsmallcell lung cancer[J]. J Clin Oncol, 1989, 7(5): 607-612. [8] Pelosi G, Sonzogni A, Galetta D, et al. Combined smallcell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle,and myofibroblastictype[J]. Virchows Arch, 2011, 458(4): 497-503. [9] 周莉, 任宝柱, 曹水, 等. 小细胞癌与鳞状细胞癌混合型肺癌1例[J]. 肿瘤, 2011, 38(24): 1527. [10] Lee SY, Shim JJ, Kang KH, et al. Curious case of combined smalland squamous cell carcinoma[J]. J Clin Oncol, 2011, 29(8): e186-187. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[3] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[4] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[5] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[6] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[7] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[8] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[9] | Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266. |
[10] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[11] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[12] | Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302. |
[13] | Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311. |
[14] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197. |
[15] | Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||